CSTL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Castle Biosciences Inc

Watchlist Manager

Watchlist

Price: 24.81 USD 1.22% Market Closed

Market Cap: $752.5m

	Castle Biosciences Inc NASDAQ:CSTL	US
	Bell Food Group AG LSE:0RFX	CH
I	IDEX Corp F:ID7	US
	Singapore Airlines Ltd F:SIA1	SG
N	Northwest Bancshares Inc F:NHS	US
M	MKS Instruments Inc SWB:MKT	US
R	Robert Half International Inc LSE:0KX9	US
	Northwest Pipe Co F:NW7	US
	ID Logistics SAS PAR:IDL	FR
	Titan Cement International SA XBRU:TITC	BE

Profitability Summary

Castle Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

78%

Strong 3Y Average Gross Margin

80%

Gross Margin is Increasing

76% > 78%

Negative Operating Margin

-10%

Negative 3Y Average Operating Margin

-16%

Operating Margin is Increasing

-58% > -10%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-12%

Net Margin is Increasing

-53% > -4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-31% > 1%

Negative ROE

-3%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-18%

ROIC is Increasing

-52% > -10%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

78%

Strong 3Y Average Gross Margin

80%

Gross Margin is Increasing

76% > 78%

Negative Operating Margin

-10%

Negative 3Y Average Operating Margin

-16%

Operating Margin is Increasing

-58% > -10%